ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163664 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163664; 2) Community: the network communities that were significantly associated with the response to NSC 163664; 3) Molecule: the relationships between components within communities and NSC 163664; 4) MDR: the compounds that were significantly associated with the NSC 163664.

NSC Compound Enrichment Correlation
NSC 708806 Null 0.0295480456086945 0.22950112
NSC 715648 Null 0.0295480456086945 -0.28827702
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.0295480456086945 -0.19552535
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.0295480456086945 -0.44178194
NSC 81052 Streptonigrin analog (MeO-N3) 0.0295480456086945 0.50345775
NSC 130862 Null 0.0314734733353265 0.44265495
NSC 154829 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride 0.0314734733353265 0.28002959
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.0314734733353267 0.47544624
NSC 294712 Lobolide 0.0314734733353267 0.49537587
NSC 3088 Chlorambucil 0.0314734733353267 0.10887465
Total:126  Current:88    [First] [Prev] [Next] [Last]